Holen Sie sich die Stockscreener-App
7.96
0.63%
0.05
Schlusskurs vom Vortag:
$7.91
Offen:
$7.68
24-Stunden-Volumen:
9,234
Relative Volume:
0.32
Marktkapitalisierung:
$10.13M
Einnahmen:
$35.75M
Nettoeinkommen (Verlust:
$11.57M
KGV:
-2.0909
EPS:
-3.8069
Netto-Cashflow:
$-26.25M
1W Leistung:
+24.37%
1M Leistung:
-2.93%
6M Leistung:
-31.20%
1J Leistung:
-68.16%
1-Tages-Spanne:
$7.68
$8.10
1-Wochen-Bereich:
$6.37
$8.10
52-Wochen-Spanne:
$6.345
$82.00
Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile
Vergleichen Sie RDHL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RDHL
Redhill Biopharma Ltd Adr
|
7.96 | 10.13M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-08-31 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-05-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-09-11 | Eingeleitet | BTIG Research | Buy |
| 2019-07-12 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2019-03-12 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2018-01-26 | Eingeleitet | Nomura | Buy |
| 2017-10-06 | Eingeleitet | Seaport Global Securities | Buy |
| 2017-10-04 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-24 | Bestätigt | FBR & Co. | Outperform |
| 2016-07-27 | Bestätigt | FBR Capital | Outperform |
| 2015-09-29 | Eingeleitet | Nomura | Buy |
| 2015-07-29 | Bestätigt | ROTH Capital | Buy |
| 2015-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-15 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Redhill Biopharma Ltd Adr Aktie (RDHL) Neueste Nachrichten
COVID-19 Competitive Landscape 2024 (Updated) - openPR
BARDA funds RedHill's opaganib for Ebola treatment - Investing.com
Medi-Cal extends Talicia access for 15 million Californians - Investing.com
RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines - StockTitan
Can Redhill Biopharma Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
RDHL stock’s current quarter earnings estimates: What analysts predict? - US Post News
Talicia® Launched in the United Arab Emirates - StockTitan
Taking on analysts’ expectations and winning: Redhill Biopharma Ltd. ADR (RDHL) - SETE News
Redhill Biopharma stock hits 52-week high of $8.03 amid volatility - Investing.com
Opaganib shows promise in obesity, diabetes treatment - Investing.com India
Balance Sheet Breakdown: Redhill Biopharma Ltd. ADR (RDHL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Redhill Biopharma Ltd. ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo Finance
Its Stock Has Paid Off Big Time For Teck Resources Ltd - SETE News
Are Smart Investors Making the Right Decision? Redhill Biopharma Ltd. ADR (RDHL) - SETE News
Check Out Aveanna Healthcare Holdings Inc (AVAH)’s Trade Data Rather Than the Analysts’ Views - SETE News
RDHL’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle
Can you now get a good deal on Redhill Biopharma Ltd. ADR’s shares? - US Post News
Is ThredUp Inc (TDUP) positioned for future growth? - SETE News
A look into Redhill Biopharma Ltd. ADR (RDHL)’s deeper side - SETE News
Immuneering Corp (IMRX) expanding its growth trajectory ahead - SETE News
Cipher Mining Inc (CIFR) is looking forward to a strong quarter - SETE News
Nothing is Better Than Hut 8 Corp (HUT) stock at the moment - SETE News
Analytical Overview: Redhill Biopharma Ltd. ADR (RDHL)’s Ratios Tell a Financial Story - The Dwinnex
Redhill Biopharma Ltd. ADR [RDHL] Revenue clocked in at $35.52 million, down -68.49% YTD: What’s Next? - The DBT News
Redhill Biopharma Ltd. ADR Inc. (RDHL) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Should investors be concerned about RDHL’s high price-to-sales ratio? - US Post News
Exact Sciences Corp. (EXAS) Stock: A Year of Decreases and Increases - The InvestChronicle
New Outlook On Alibaba Group Holding Ltd ADR - Stocks Register
Baker Hughes Co (NASDAQ: BKR) Up 1.26%: This Is What Analysts Are Now Forecasting - Stocks Register
Redhill Biopharma Ltd. ADR (RDHL) requires closer examination - US Post News
Redhill Biopharma Ltd. ADR (RDHL) Stock: A Year of Market Fluctuations - The InvestChronicle
Ratio Examination: Redhill Biopharma Ltd. ADR (RDHL)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
RedHill Biopharma finalizes agreement to enhance cash position - Investing.com India
Redhill Biopharma Ltd. ADR (RDHL)'s stock performance: a year in review – US Post News - US Post News
RedHill's (RDHL) RHB-204 Gets FDA Orphan Drug Designation - Yahoo Lifestyle UK
Ratio Analysis: Unpacking Redhill Biopharma Ltd. ADR (RDHL)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
Should investors be concerned about Redhill Biopharma Ltd. ADR (RDHL)? – US Post News - US Post News
RedHill (RDHL) Down on Unsatisfactory Data From COVID-19 Study - Yahoo News UK
Emerging Technologies in the Proton Pump Inhibitors Market to Hit US$ 3.5 Billion by 2031 - openPR
The Psychology of Redhill Biopharma Ltd. ADR Inc. (RDHL) Price Performance: Understanding Market Sentiment - The InvestChronicle
RedHill Biopharma secures $1.25 million in direct offering By Investing.com - Investing.com
KALA Stock Quote Price and Forecast - CNN
RedHill secures new US patent for H. pylori treatment Talicia - Investing.com
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 - PR Newswire
Balancing Acidity: Exploring the Proton Pump Inhibitors Market - openPR
symbol__ Stock Quote Price and Forecast - CNN
RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034 - Yahoo Finance
LLY Stock Quote Price and Forecast - CNN
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. - PR Newswire
Phil and RedHill Biopharma Partner to Increase Access to Talicia® - Business Wire
Finanzdaten der Redhill Biopharma Ltd Adr-Aktie (RDHL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):